A disruptive leap in non-contrast MRA
More than 200 million people worldwide suffer from peripheral arterial disease (PAD).1,2
Contraindication of contrast media makes it challenging to diagnose a large number of these patients.
Overcome these current limitations and enhance your clinical capabilities with QISS, a completely new non-contrast MR Angiography technique.
QISS aids in improving patient safety and compliance for higher accuracy3 and better disease management, while maintaining the diagnostic certainty you need in peripheral MRA exams.